Edition:
India

Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11


Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Cleveland BioLabs Inc :Cleveland BioLabs reports third quarter 2017 financial results and development progress.Q3 revenue $300,000 versus $1.1 million.Cleveland BioLabs Inc - qtrly ‍net loss, excluding minority interests, $0.11 per share​.Cleveland BioLabs -current cash,cash equivalents,short-term investments is expected to fund operations for at least 1 year beyond filing date of form 10-Q​. 

Company Quote

1.08
 --
20 Sep 2019